Design of a dual nanostructured lipid carrier formulation based on physicochemical, rheological, and mechanical properties
Source abstract
Abstract
The synergy between nanostructured lipid carriers (NLC) and chemical penetration enhancers provides the basis for a promising strategy to effectively deliver drugs through the skin. In the present work, focus is given to the study of the interaction of limonene, ethanol, and Carbopol Ultrez® 10NF, as the gelling agent, with a co-encapsulating NLC dispersion, containing both olanzapine and simvastatin. The analysis is based on rheological, mechanical, and physicochemical properties. The nanoparticle size ranged from 130 to 400 nm, depending on the system considered. The inclusion of carbopol resulted in a considerable increase in the NLC particle size, which was attributed to carbomer bridging nanoparticles, resulting in some particle aggregation. Rheological measurements indicated that the viscosity of the neat carbopol hydrogel was reduced by the enhancers and to a higher extent by the presence of NLC. A more apolar medium can be pointed out as a general explanation, while a polymer/nanoparticle hydrophobic interaction coupled with surfactant/polymer H-bonding provides the rationale for the NLC effect. The inclusion of enhancers and a carbomer largely contributed to the physicochemical stability of the NLC formulation, as revealed by the low transmission profiles and more negative zeta potential values.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Dermatology and Skin Diseases · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (33)
Show source-provided references
1. Barreiro-Iglesias R, Alvarez-Lorenzo C, Concheiro A (2003) Poly(acrylic acid) microgels (Carbopol® 934)/surfactant interactions in aqueous media: part I: nonionic surfactants. Int J Pharm 258(1–2):165–177. doi: 10.1016/S0378-5173(03)00181-910.1016/S0378-5173(03)00181-9 ↗
2. Bruschi ML, Jones DS, Panzeri H, Gremião MPD, de Freitas O, Lara EHG (2007) Semisolid systems containing propolis for the treatment of periodontal disease: in vitro release kinetics, syringeability, rheological, textural, and mucoadhesive properties. J Pharm Sci 96(8):2074–2089. doi: 10.1002/jps.2084310.1002/jps.20843 ↗
3. Contreras MD, Sánchez R (2002) Application of a factorial design to the study of specific parameters of a Carbopol ETD 2020 gel. Part I. Viscoelastic parameters. Int J Pharm 234(1–2):139–14710.1016/S0378-5173(01)00953-X ↗
4. Detloff T, Sobisch T, Lerche D (2007) Particle size distribution by space or time dependent extinction profiles obtained by analytical centrifugation (concentrated systems). Powder Technol 174(1–2):50–55. doi: 10.1016/j.powtec.2006.10.02110.1016/j.powtec.2006.10.021 ↗
5. Doktorovova S, Souto EB (2009) Nanostructured lipid carrier-based hydrogel formulations for drug delivery: a comprehensive review. Expert Opin Drug Deliv 6(2):165–176. doi: 10.1517/1742524080271259010.1517/17425240802712590 ↗
6. Ferry JD (1948) Viscoelastic properties of polymer solutions. J Res Natl Bur Stand 41(1):53–6210.6028/jres.041.008 ↗
7. Fresno MJC, Ramírez AD, Jiménez MM (2002) Systematic study of the flow behaviour and mechanical properties of Carbopol® Ultrez™ 10 hydroalcoholic gels. Eur J Pharm Biopharm 54(3):329–335. doi: 10.1016/s0939-6411(02)00080-210.1016/S0939-6411(02)00080-2 ↗
8. Gane PAC, Ridgway CJ, Lehtinen E, Valiullin R, Furó I, Schoelkopf J, Paulapuro H, Daicic J (2004) Comparison of NMR cryoporometry, mercury intrusion porosimetry, and DSC thermoporosimetry in characterizing pore size distributions of compressed finely ground calcium carbonate structures. Ind Eng Chem Res 43(24):7920–7927. doi: 10.1021/ie049448p10.1021/ie049448p ↗
9. Holmberg K, Jönsson B, Kronberg B, Lindman B (2003) Polymers in solution. In: Surfactants and polymers in aqueous solution. John Wiley & Sons, Ltd, pp 193–214. doi: 10.1002/0470856424.ch910.1002/0470856424.ch9 ↗
10. Jain AK, Thomas NS, Panchagnula R (2002) Transdermal drug delivery of imipramine hydrochloride: I. Effect of terpenes. J Controlled Release 79(1–3):93–101. doi: 10.1016/s0168-3659(01)00524-710.1016/S0168-3659(01)00524-7 ↗
11. Jones DS, Woolfson AD, Djokic J (1996) Texture profile analysis of bioadhesive polymeric semisolids: mechanical characterization and investigation of interactions between formulation components. J Appl Polym Sci 61(12):2229–2234. doi: 10.1002/(sici)1097-4628(19960919)61:12<2229:aid-app24>3.0.co;2-010.1002/(SICI)1097-4628(19960919)61:12<2229::AID-APP24>3.0.CO;2-0 ↗
12. Jones DS, Woolfson AD, Brown AF (1997a) Textural analysis and flow rheometry of novel, bioadhesive antimicrobial oral gels. Pharm Res 14(4):450–457. doi: 10.1023/a:101209123102310.1023/A:1012091231023 ↗
13. Jones DS, Woolfson AD, Brown AF, O’Neill MJ (1997b) Mucoadhesive, syringeable drug delivery systems for controlled application of metronidazole to the periodontal pocket: in vitro release kinetics, syringeability, mechanical and mucoadhesive properties. J Controlled Release 49(1):71–79. doi: 10.1016/s0168-3659(97)00060-610.1016/S0168-3659(97)00060-6 ↗
14. Jones DS, Brown AF, Woolfson AD (2001) Rheological characterization of bioadhesive, antimicrobial, semisolids designed for the treatment of periodontal diseases: transient and dynamic viscoelastic and continuous shear analysis. J Pharm Sci 90(12):1978–1990. doi: 10.1002/jps.114910.1002/jps.1149 ↗
15. Junyaprasert VB, Teeranachaideekul V, Souto EB, Boonme P, Müller RH (2009) Q10-loaded NLC versus nanoemulsions: stability, rheology and in vitro skin permeation. Int J Pharm 377(1–2):207–214. doi: 10.1016/j.ijpharm.2009.05.02010.1016/j.ijpharm.2009.05.020 ↗
16. Krakowski M, Czobor P, Citrome L (2009) Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol. Schizophr Res 110(1–3):95–102. doi: 10.1016/j.schres.2009.02.00610.1016/j.schres.2009.02.006 ↗
17. Lerche D (2002) Dispersion stability and particle characterization by sedimentation kinetics in a centrifugal field. J Dispersion Sci Technol 23(5):699–70910.1081/DIS-120015373 ↗
18. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RSE, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353(12):1209–1223. doi: 10.1056/NEJMoa05168810.1056/NEJMoa051688 ↗
19. Müller RH, Radtke M, Wissing SA (2002a) Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242(1–2):121–12810.1016/S0378-5173(02)00180-1 ↗
20. Müller RH, Radtke M, Wissing SA (2002b) Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54(Supplement 1):S131–S15510.1016/S0169-409X(02)00118-7 ↗
21. Müller RH, Shegokar R, Keck CM (2011) 20 Years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications. Curr Drug Discov Technol 8(3):207–22710.2174/157016311796799062 ↗
22. Pardeike J, Hommoss A, Müller RH (2009) Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 366(1–2):170–18410.1016/j.ijpharm.2008.10.003 ↗
23. Pardeike J, Schwabe K, Müller RH (2010) Influence of nanostructured lipid carriers (NLC) on the physical properties of the Cutanova Nanorepair Q10 cream and the in vivo skin hydration effect. Int J Pharm 396(1–2):166–173. doi: 10.1016/j.ijpharm.2010.06.00710.1016/j.ijpharm.2010.06.007 ↗
24. Prasad R, Anand S, Khar RK, Dinda AK, Koul V (2009) Studies on in vitro and in vivo transdermal flux enhancement of methotrexate by a combinational approach in comparison to oral delivery. Drug Dev Ind Pharm 35(11):1281–1292. doi: 10.3109/0363904090288232210.3109/03639040902882322 ↗
25. Şenyiğit T, Tekmen I, Sönmez Ü, Santi P, Özer Ö (2011) Deoxycholate hydrogels of betamethasone-17-valerate intended for topical use: in vitro and in vivo evaluation. Int J Pharm 403(1–2):123–129. doi: 10.1016/j.ijpharm.2010.10.03610.1016/j.ijpharm.2010.10.036 ↗
26. Silva SMC, Pinto FV, Antunes FE, Miguel MG, Sousa JJS, Pais AACC (2008) Aggregation and gelation in hydroxypropylmethyl cellulose aqueous solutions. J Colloid Interface Sci 327(2):333–340. doi: 10.1016/j.jcis.2008.08.05610.1016/j.jcis.2008.08.056 ↗
27. Silva AC, Santos D, Ferreira DC, Souto EB (2009) Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations. Pharmazie 64(3):177–182
28. Sobisch T, Lerche D (2008) Thickener performance traced by multisample analytical centrifugation. Colloids Surf A 331(1–2):114–118. doi: 10.1016/j.colsurfa.2008.05.04010.1016/j.colsurfa.2008.05.040 ↗
29. Souto EB, Wissing SA, Barbosa CM, Müller RH (2004) Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. Eur J Pharm Biopharm 58(1):83–90. doi: 10.1016/j.ejpb.2004.02.01510.1016/j.ejpb.2004.02.015 ↗
30. Souto EB, Almeida AJ, Müller RH (2006) SLN and NLC as viscoelastic enhancers for topical drug delivery. Proceeding XIV international workshop on bioencapsulation & COST 865 meeting (Lausanne, Switzerland) O6-5
31. Vitorino C, Almeida J, Gonçalves LM, Almeida AJ, Sousa JJ, Pais AACC (2013) Co-encapsulating nanostructured lipid carriers for transdermal application: from experimental design to the molecular detail. J Controlled Release 167(3):301–314. doi: 10.1016/j.jconrel.2013.02.01110.1016/j.jconrel.2013.02.011 ↗
32. Williams AC, Barry BW (2004) Penetration enhancers. Adv Drug Deliv Rev 56(5):603–618. doi: 10.1016/j.addr.2003.10.02510.1016/j.addr.2003.10.025 ↗
33. Yaprak Karavana S, Güneri P, Ertan G (2009) Benzydamine hydrochloride buccal bioadhesive gels designed for oral ulcers: preparation, rheological, textural, mucoadhesive and release properties. Pharm Dev Technol 14(6):623–631. doi: 10.3109/1083745090288235110.3109/10837450902882351 ↗